Alexis Baass Selected Research

Myocardial Infarction

1/2024	Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.
5/2023	Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia.
10/2021	Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia.
7/2021	ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia.
1/2021	Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
9/2020	The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexis Baass Research Topics

Disease

25	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2023 - 09/2009
22	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 12/2014
8	Hyperlipoproteinemia Type III (Broad Beta Disease) 04/2024 - 12/2009
6	Myocardial Infarction 01/2024 - 09/2020
5	Dyslipidemias (Dyslipidemia) 04/2024 - 09/2018
5	Insulin Resistance 03/2020 - 09/2009
4	Pancreatitis 02/2024 - 03/2018
4	Stroke (Strokes) 01/2024 - 01/2021
4	Xanthomatosis (Xanthoma) 01/2022 - 07/2016
4	Hypertension (High Blood Pressure) 10/2021 - 09/2017
4	Inborn Genetic Diseases (Disease, Hereditary) 10/2020 - 07/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2023 - 10/2017
3	Hypercholesterolemia 11/2022 - 11/2014
3	Hypertriglyceridemia 01/2021 - 05/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2018 - 05/2017
2	Homozygous Familial Hypercholesterolemia 01/2024 - 10/2020
2	Non-alcoholic Fatty Liver Disease 10/2023 - 07/2023
2	Unstable Angina 10/2021 - 07/2021
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2021 - 03/2018
2	Atherosclerosis 10/2020 - 10/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
2	Genetic Risk Score 01/2018 - 05/2017
1	Sitosterolemia 05/2024
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023
1	Deficiency Diseases (Deficiency Disease) 01/2022
1	Apolipoprotein B Familial Hypobetalipoproteinemia 01/2022
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2022
1	Costello Syndrome 01/2021
1	Transient Ischemic Attack 01/2021
1	Hyperlipidemias (Hyperlipidemia) 09/2018
1	Atherosclerotic Plaque (Atheroma) 03/2018
1	Arcus Senilis 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 07/2016
1	Inflammation (Inflammations) 11/2012
1	Renal Insufficiency (Renal Failure) 12/2009
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 12/2009
1	Corneal Opacity 12/2009
1	Anemia 12/2009
1	Proteinuria 12/2009

Drug/Important Bio-Agent (IBA)

19	LDL CholesterolIBA 03/2024 - 12/2014
16	oxidized low density lipoproteinIBA 01/2024 - 09/2009
11	Lipoproteins (Lipoprotein)IBA 04/2024 - 05/2013
10	LipidsIBA 05/2024 - 07/2016
10	Triglycerides (Triacylglycerol)IBA 10/2023 - 11/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 01/2018
5	Proprotein Convertase 9IBA 03/2020 - 11/2014
5	Apolipoproteins B (ApoB)IBA 01/2020 - 05/2013
4	omega-Chloroacetophenone (Mace)IBA 01/2024 - 07/2021
4	ApolipoproteinsIBA 12/2022 - 01/2020
4	Apolipoproteins E (ApoE)IBA 10/2022 - 12/2009
4	Lipoprotein(a)IBA 10/2021 - 11/2014
3	CholesterolIBA 10/2022 - 01/2022
3	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2017
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2017
3	HDL CholesterolIBA 10/2021 - 05/2017
3	PCSK9 InhibitorsIBA 09/2018 - 01/2018
2	TransferasesIBA 10/2023 - 01/2021
2	Ezetimibe (Zetia)FDA Link 10/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2018
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 11/2022 - 01/2017
2	Apolipoprotein C-II (ApoC2)IBA 01/2021 - 03/2018
2	Apolipoprotein E2IBA 07/2020 - 12/2009
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	evolocumabIBA 01/2019 - 09/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2009
2	Insulin (Novolin)FDA Link 08/2013 - 09/2009
1	Phytosterols (Plant Sterols)IBA 05/2024
1	SterolsIBA 05/2024
1	C-Reactive ProteinIBA 02/2024
1	Kazal Pancreatic Trypsin InhibitorIBA 02/2024
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	CalciumIBA 01/2021
1	FructoseIBA 01/2021
1	BMS201038IBA 10/2020
1	NucleotidesIBA 10/2020
1	VLDL CholesterolIBA 07/2020
1	BilirubinIBA 03/2020
1	AlbuminsIBA 03/2020
1	Alkaline PhosphataseIBA 03/2020
1	Atorvastatin (Lipitor)FDA Link 01/2019
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2018
1	ABO Blood-Group SystemIBA 03/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2017
1	LectinsIBA 10/2017
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 10/2017
1	Apolipoprotein B-48IBA 01/2017
1	SubtilisinIBA 01/2017
1	ChylomicronsIBA 01/2017
1	O(4)-methylthymidine triphosphateIBA 07/2016
1	Apolipoprotein E3IBA 08/2013
1	LeptinIBA 08/2013
1	Apolipoproteins C (ApoC)IBA 11/2012
1	HDL LipoproteinsIBA 11/2012
1	EnzymesIBA 12/2009
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 12/2009

Therapy/Procedure

6	Therapeutics 05/2024 - 01/2018
1	Carotid Endarterectomy 01/2021